Ray Dalio's ENOV Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 51,224 shares of Enovis Corporation (ENOV) worth $1.17 M, representing 0.01% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in ENOV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 51,224 shares. Largest reduction occurred in Q4 2022, reducing 47,041 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Enovis Corporation (ENOV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Enovis Corporation (ENOV) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +51,224 | New Buy | 51,224 | $22.75 |
| Q1 2025 | -5,915 | Sold Out | 0 | $0.00 |
| Q4 2024 | -11,673 | Reduce 66.37% | 5,915 | $43.88 |
| Q3 2024 | +7,823 | Add 80.11% | 17,588 | $43.05 |
| Q2 2024 | -192 | Reduce 1.93% | 9,765 | $45.20 |
| Q1 2024 | -1,935 | Reduce 16.27% | 9,957 | $62.45 |
| Q4 2023 | -3,172 | Reduce 21.06% | 11,892 | $56.02 |
| Q3 2023 | -40,932 | Reduce 73.10% | 15,064 | $52.73 |
| Q2 2023 | -3,083 | Reduce 5.22% | 55,996 | $64.12 |
| Q1 2023 | +42,637 | Add 259.32% | 59,079 | $53.49 |
| Q4 2022 | -47,041 | Reduce 74.10% | 16,442 | $53.52 |
| Q3 2022 | -4,853 | Reduce 7.10% | 63,483 | $46.08 |
| Q2 2022 | +68,336 | New Buy | 68,336 | $54.99 |
Ray Dalio's Enovis Corporation Investment FAQs
Ray Dalio first purchased Enovis Corporation (ENOV) in Q2 2022, acquiring 68,336 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Enovis Corporation (ENOV) for 13 quarters since Q2 2022.
Ray Dalio's largest addition to Enovis Corporation (ENOV) was in Q2 2022, adding 68,336 shares worth $3.76 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 51,224 shares of Enovis Corporation (ENOV), valued at approximately $1.17 M.
As of the Q1 2026 filing, Enovis Corporation (ENOV) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Enovis Corporation (ENOV) was 68,336 shares, as reported at the end of Q2 2022.